Telix Pharmaceuticals | TLX - Cost Of Sales

Stock Price
13.65
Daily Change
0.73 5.65%
Monthly
39.86%
Yearly
-50.70%
Q1 Forecast
12.64

Telix Pharmaceuticals reported AUD221.36M in Cost of Sales for its fiscal semester ending in December of 2025.





Cost Of Sales Change Date
Cochlear AUD 319.2M 160.35M Dec/2025
CSL USD 3.87B 2.08B Dec/2025
Integral Diagnostics AUD 11.53M 146K Jun/2024
Mayne Pharma AUD 43.74M 2.67M Jun/2024
Medical Developments International AUD 7.09M 4.91M Dec/2025
Mesoblast USD -7.6M 27.47M Dec/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Pacific Edge NZD 280K 0 Mar/2024
Paradigm Biopharmaceuticals AUD 4.5K 2.62K Dec/2025
Polynovo AUD 9.02M 3.51M Dec/2025
Ramsay Health Care AUD 3.05B 78.7M Dec/2025
ResMed USD 536.28M 21.52M Dec/2025
Sonic Healthcare AUD 751.66M 801.13M Dec/2024